Introduction
Infectious bursal disease virus (IBDV) is the causative agent of an economically important disease affecting juvenile domestic chickens (Gallus gallus). The virus infects pre-B lymphocytes present within the bursa of Fabricius, causing a severe immune depression (for reviews see Narajan & Kibenge, 1995 ; Kibenge et al., 1988) . IBDV is the prototype member of the genus Avibirnavirus of the family Birnaviridae (Dobos et al., 1979 (Dobos et al., , 1995 . Birnaviruses are non-enveloped icosahedral viruses with a genome formed by two molecules of doublestranded RNA (dsRNA). The larger RNA segment (3n2 kb) contains two partially overlapping open reading frames (ORFs), A1 and A2. ORF A2 encodes a 17 kDa protein, VP5 (Mundt et al., 1995) , recently shown to be non-essential for virus replication in vitro (Mundt et al., 1997) . ORF A1 encodes a 106 kDa polyprotein that is self-processed to give three mature proteins : VP2 (50-52 kDa) ; VP3 (30-32 kDa) ; and VP4 (27-30 kDa). VP2 and VP3 form the viral capsid, and VP4 appears to be responsible for proteolytic cleavage of the polyprotein (Hudson et al., 1986) . The smaller RNA segment (2n9 kb) encodes a 90 kDa protein, VP1, which has RNAdependent RNA polymerase activity, binds to both genomic dsRNA molecules and is encapsidated into the virus particle (Mu$ ller & Nitschke, 1987) .
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Fax j34 1 5854506. e-mail jfrodrig!cnb.uam.es of cells infected with the recombinant virus contains abundant IBDV-like particles (VLP). These VLP form close-packed paracrystalline arrays that are specifically recognized by anti-IBDV antibodies. The size and morphology of purified VLP were found to be akin to those of authentic IBDV particles.
Elucidation of the three-dimensional structure of the IBDV particle has shown that its architecture is based on a T l 13 lattice formed by trimeric subunits (Bo$ tcher et al., 1997) . According to the currently accepted model, VP2 would form the external surface of the virion while VP3, the second structural protein, would face the interior of the particle, probably interacting with the genomic RNA molecules through its negatively charged C terminus (Bo$ tcher et al., 1997 ; Hudson et al., 1986) . The lack of suitable experimental systems has hampered attempts to test this model.
Although the IBDV polyprotein has been expressed in several systems including E. coli (Jagadish et al., 1988) , yeast (Jagadish et al., 1990) , and insect cells infected with recombinant baculovirus (Vakharia et al., 1993) , there have been no reports on whether its expression in mammalian cells would lead to the formation of virus-like particles (VLP). We have analysed the feasibility of producing empty IBDV particles using an experimental approach based on the inducible expression of ORF A1 using a vaccinia virus vector.
Analysis of protein expression. BSC-1 cells were infected with either VT7LacOI or VT7LacOI\POLY at an m.o.i. of 10 p.f.u. per cell and maintained either in the presence or the absence of the inducer IPTG (4 mM final concentration). At 18 h post-infection (p.i.), cells were washed twice with methionine-free DMEM, and metabolically labelled for 30 min with 50 µCi\ml [$&S]methionine, washed twice with PBS, and resuspended in 1i sample buffer (62n5 mM Tris-HCl, pH 6n8; 2% SDS; 0n25 % bromophenol blue ; 5 % glycerol ; and 5 % β-mercaptoethanol). Protein samples (5-10 µg per sample) were analysed by 15 % SDS-PAGE followed by autoradiography.
For Western blots, after electrophoresis the gels were transferred to nitrocellulose filters by electroblotting. After transfer, the filters were incubated for 2 h in blocking buffer (PBS containing 5 % non-fat dry milk), and then maintained for 16 h at 5 mC with a 1\200 dilution of either anti-VP2 or anti-VP3 antisera in blocking buffer, washed with PBS, and then incubated for 1 h with a 1\500 dilution of goat anti-rabbit IgG conjugated with horseradish peroxidase (ICN) in blocking buffer. After washing with PBS, the membranes were developed in PBS containing 0n02 % 1-chloro-4-naphthol and 0n006 % hydrogen peroxide.
Anti-VP2 and anti-VP3 antisera were obtained from rabbits immunized with either peptide CDSSDRPRVYTITAADDYQ or QVKY-WQNKREIPDPNEDY-C, covering sequences 197-215 and 887-904 respectively of the polyprotein molecule. These peptides were synthesized on an automated multiple peptide synthesizer (AMS 422, Abimed) using a solid-phase procedure and standard Fmoc-chemistry (Gausepohl et al., 1992) . The C-terminal Cys of the second peptide was included for coupling purposes. Purity and composition of peptides were confirmed by reverse-phase high-performance liquid chromatography on a C-18 Nucleosil 120 analytical column (Tracer) with a 5-70 % acetonitrile gradient containing 1 % trifluoroacetic acid, and by amino acid analysis using a Beckman 6300 amino acid analyser, after acid hydrolysis in a nitrogen atmosphere for 18 h at 110 mC. These peptides were coupled to keyhole limpet haemocyanin (KLH, Pierce) via either the N-or the Cterminal Cys using the linking agent sulpho-succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC). The molar ratio of peptide : carrier conjugated was estimated by amino acid analysis of the complex relative to the amino acid analysis of the carrier protein alone. These conjugates were used as immunogens to induce antibodies specific for VP2 and VP3 polypeptides.
Anti-IBDV antiserum was obtained from chickens immunized with purified inactivated virus.
Purification of IBDV-like particles.
Cultures of BSC-1 cells were infected with VT7LacOI\POLY at an m.o.i. of 10 p.f.u. per cell and maintained in the presence of IPTG. At 20 h p.i. cells were collected and used to purify VLP. Cells were resuspended in TEN buffer (10 mM TrisHCl, pH 7n2 ; 100 mM NaCl ; and 1 mM EDTA) and subjected to three cycles of freeze-thawing. After removing the cell debris by low speed centrifugation (10 000 g for 20 min at 4 mC), the supernatant was recovered, loaded on top of a 5 ml cushion of 30 % (w\w) sucrose in TNE buffer, and spun at 125 000 g for 3 h at 4 mC. After centrifugation, the pellet was thoroughly resuspended in TNE buffer and CsCl added to reach a density of 1n30 g\ml. The preparation was then centrifuged at 250 000 g for 20 h at 20 mC. After centrifugation, a band was clearly visible towards the top of the gradient. This band was collected by suction with a syringe fitted with a hypodermic needle, and analysed by electron microscopy.
Electron microscopy. Purified IBDV-like particles were attached to electron microscopy (EM) copper grids covered with collodion and carbon that had previously been made hydrophilic by glow discharge. These grids were placed on drops of the VLP suspension, and incubated for 2 min. Adsorbed particles were negatively stained for 30 s with a 2 % solution of uranyl acetate. Some of the samples were processed for immunogold labelling according to established procedures (Risco et al., 1996) . VLP adsorbed to EM gold grids covered by Formvar and carbon were incubated for 5 min with Tris buffer-gelatin (TBG) [30 mM Tris-HCl (pH 8n0) containing 150 mM NaCl, 0n1 % BSA and 1 % gelatin] and then with the anti-IBDV chicken antiserum described above, diluted 1 : 50 in TBG. After 15 min the samples were washed with TBG and incubated for 15 min with a rabbit anti-chicken IgG (5 µg\ml in TBG) obtained from Sigma. After washing again with TBG, labelling was completed with a 15 min incubation in an anti-rabbit IgG conjugated with 5 or 10 nm gold particles (BioCell). After washing with TBG and distilled water, samples were negatively stained as indicated above and studied in a JEOL 1200 EX II electron microscope.
Cultured BSC-1 cells infected as described above were fixed in situ with a mixture of 2 % glutaraldehyde and 2 % tannic acid in 0n4 M HEPES buffer (pH 7n5) for 1 h at room temperature. Fixed monolayers were removed from the culture dishes in the fixative and transferred to Eppendorf tubes. After centrifugation and washing with HEPES buffer, cells were post-fixed with a mixture of 1 % osmium tetroxide and 0n8% potassium ferricyanide in distilled water and processed for embedding in resin EML-812 (EML Laboratories) as previously described (Risco et al., 1996) . Ultra-thin sections of the samples were either immunolabelled with the anti-IBDV chicken antiserum and a 10 nm colloidal gold conjugate, according to described procedures (Risco et al., 1996) , or directly stained with saturated uranyl acetate and lead citrate and studied by electron microscopy.
Results

Expression of ORF A1 in recombinant VV-infected cells
We sought to analyse the feasibility of producing IBDV VLP using a strategy based on the expression of the IBDV ORF A1 using a VV inducible expression system (Ward et al., 1995) .
A transfer vector, pVOTE\POLY, containing ORF A1 of IBDV under the control of an inducible version of the T7 RNA polymerase promoter, was constructed and used to generate the recombinant virus VT7LacOI\POLY. After purification and amplification, the genomic structure of VT7LacOI\POLY was analysed by PCR and DNA hybridization and found to be correct (data not shown).
The expression of ORF A1 in BSC-1 cells infected with VT7LacOI\POLY was analysed. Cells were infected at an m.o.i. of 10 p.f.u. per cell with either VT7LacOI\POLY or the parental virus VT7LacOI. After infection, cultures were maintained in the presence or the absence of the inducer IPTG. At 18 h p.i. cells were metabolically labelled and the corresponding protein extracts analysed by SDS-PAGE. The results of this analysis, shown in Fig. 1 (A) , demonstrate that addition of IPTG to VT7LacOI\POLY-infected cells results in the specific expression of four polypeptides of approximately 100, 50, 32 and 28 kDa, respectively. The larger polypeptide (100 kDa) corresponds to the T7 RNA polymerase, which is also found in IPTG-induced BSC-1 cells infected with the parental virus VT7LacOI (Fig. 1 A) . The electrophoretic mobilities of the other three IPTG-induced polypeptides correspond to those detected after processing of the IBDV polyprotein (Hudson et al., 1986) .
The identity of the IPTG-induced polypeptides was further confirmed by Western blot analysis. Protein extracts obtained from BSC-1 cells infected with VT7LacOI\POLY, maintained in the presence or the absence of IPTG, and from purified IBDV, were subjected to SDS-PAGE and blotted to nitrocellulose filters. After blotting, the filters were probed with either anti-VP2 or anti-VP3 antisera. As shown in Fig. 1 (B) the anti-VP3 antiserum recognizes a single protein band of 32 kDa present in extracts from purified IBDV and IPTG-induced VT7LacOI\POLY-infected BSC-1 cells. The anti-VP2 antiserum recognizes a band corresponding to a polypeptide with an electrophoretic mobility of 50 kDa in the lanes corresponding to samples from purified IBDV and IPTG-induced VT7LacOI\POLY-infected BSC-1 cells. A minor band of approximately 20 kDa is also recognized in these two lanes. The origin of this band is unknown. In addition, the anti-VP2 antiserum recognizes a polypeptide of approximately 100 kDa (Fig. 1 B) . A band with this apparent molecular mass was detected in samples from cells infected with the parental virus VT7LacOI only after induction with IPTG (data not shown), indicating that it might correspond to T7 polymerase. The likelihood of this is strengthened by the finding that preimmune serum, obtained from the same rabbit used to produce the anti-VP2 antiserum, also recognizes the IPTG-inducible 100 kDa band in extracts from both VT7LacOI-and VT7LacOI\POLY-infected BSC-1 (data not shown). A band of approximately 40 kDa is recognized in all lanes, indicating that it might correspond to a protein of cellular origin.
These data show that inducible expression of IBDV ORF A1 in cells infected with the recombinant virus VT7LacOI\ POLY specifically results in the accumulation of three polypeptides with the expected molecular mass and, in the case of the structural polypeptides VP2 and VP3, the same antigenic specificity as those expressed in IBDV-infected CEF.
Detection of IBDV virus-like particles in VT7LacOI/POLY-infected cells
After establishing that expression of IBDV ORF A1 in mammalian cells leads to the accumulation of the structural proteins VP2 and VP3, it was important to analyse whether they would assemble to form VLP. To test this hypothesis, BSC-1 cells were infected with VT7LacOI\POLY, maintained in the presence of IPTG, and at 20 h p.i. fixed and processed for thin-section transmission electron microscopy.
As shown in Fig. 2 (A) , in addition to the presence of large mature and immature VV particles, the cytoplasm of the infected cells was studded with accumulations of smaller isometric particles with a morphology and size (diameter of approximately 60 nm) (Fig. 2 C, D) which strongly resemble the appearance of particles found within the cytoplasm of IBDV-infected cells (Kaufer & Weiss, 1976) . The VLP accumulate, forming close-packed paracrystalline arrays that, as shown in Fig. 2 (B) , are specifically recognized by an anti-IBDV polyclonal antiserum. VLP were never found within the cell nucleus. Very low levels of VLP were detected within the extracellular medium, indicating that they are not actively released from the infected cells.
These results demonstrate that expression of ORF A1 results in the formation of virus-like particles in the absence of other IBDV proteins and genomic RNA fragments.
Purification of IBDV-like particles
Cultures of BSC-1 cells were infected with VT7LacOI\ POLY at an m.o.i. of 10 p.f.u. per cell and maintained in the presence of IPTG. At 20 h p.i. cells were collected and used to purify the VLP according to the protocol described in Methods.
As shown in Fig. 3 (A) , the fraction obtained after centrifugation through the sucrose cushion contained two types of particles : (i) large (ca. 250 nm) brick-shaped VV virions ; and (ii) icosahedral VLP with a diameter of 60-65 nm. In contrast, the band collected from the CsCl gradient was shown to contain exclusively VLP. Both the size and symmetry of VLP are identical to those described for genuine IBDV particles (Hirai & Shimakura, 1974 ; Nick et al., 1976) . The VLP are strongly recognized by anti-IBDV antiserum (Fig. 3 B, D) , thus further confirming their identity.
Discussion
We have shown that inducible expression of IBDV ORF A1 in cells infected with the recombinant VV VT7LacOI\POLY results in the accumulation of three polypeptides with the molecular size of the mature processed products, VP2, VP3 and VP4. The identity of the structural proteins VP2 and VP3 expressed in our system was further assessed by Western blot using specific antisera. Although a direct demonstration is still lacking, previous results strongly indicate that proteolytic processing of the 106 kDa IBDV polyprotein is carried out by VP4, in what appears to be a cotranslational event (Jagadish et al., 1988 (Jagadish et al., , 1990 Vakharia et al., 1993) . The presence of unprocessed polyprotein was not detectable either by Western blot analysis or by immune precipitation using specific anti-VP2 and anti-VP3 antisera (data not shown), supporting the hypothesis that biosynthesis and processing of the IBDV polyprotein are coupled processes.
The existence of an intermediate processing product, designated as VPX or VP2a, a precursor of VP2 with a molecular mass of 47-48 kDa, has been documented. The efficiency of the proteolytic event required to produce VP2 from VPX seems to be dependent upon the IBDV strain (Becht, 1980 ; Mu$ ller & Becht, 1982) . Interestingly, the presence of VPX was not detected in extracts obtained from either purified IBDV or BSC-1 cells expressing ORF A1 (Fig. 1 A, B) .
It was expected that cells expressing ORF A1 would accumulate the VP2, VP3 and VP4 polypeptides in an approximately equivalent ratio. However, the results obtained contradicted this expectation. According to the intensity of their corresponding radioactive bands, VP3 and VP4 appear to accumulate in a 1 : 1 molar ratio. However, the amount of VP2 found in the cell extracts is much lower than expected, especially when it is considered that VP2 contains nine methionine residues while VP3 and VP4 possess nine and four, respectively.
A series of pulse-chase experiments showed that the VP2 : VP3 : VP4 ratio is not significantly altered after chasing (data not shown). In addition to this, VP2 was not found to be secreted from the infected cells (data not shown). These data suggest that VP3 and VP4 are synthesized in greater amounts than VP2. A somewhat similar observation was obtained after expression of ORF A1 in yeast cells (Jagadish et al., 1990) and E. coli (Macreadie & Azad, 1991) . As suggested by Jagadish et al. (1990) , the existence of an internal cap-independent translational initiation site in close proximity to the VP2-VP4 proteolytic site would explain these results. In the expression system described here the 5h end of the ORF A1 transcripts contains a leader sequence from the encephalomyocarditis virus RNA. This leader sequence acts as a very efficient capindependent translation initiation site (Elroy-Stein et al., 1989) and might affect the secondary structure and, consequently, the translatability of these mRNAs. Therefore, the significance of our observation is, as yet, unclear. Experiments aimed to identify the possible presence of an internal translational initiation site in ORF A1 mRNA are under way.
We have recently shown that VP2 is a potent apoptotic inducer (Ferna! ndez-Arias et al., 1997) . Expression of the region encoding VP2 using the VV VOTE system triggers a programmed cell death response in a wide variety of mammalian cell lines, including BSC-1 cells. Expression of the complete polyprotein also triggers apoptosis but with a significantly lower efficiency than that observed after expression of VP2 alone (data not shown). Although the reason for this difference is unknown, it seems feasible that when expressed within the context of the full polyprotein, a large fraction of the VP2 produced would be ' sequestered ' within VLP, whilst the VP2 expressed in the absence of other structural components of the virus would be free to interact with cellular factor(s), triggering an apoptotic response.
The results presented demonstrate that expression of ORF A1 in cells infected with the recombinant virus VT7LacOI\ POLY leads to the formation of IBDV VLP. These VLP accumulate within the cytoplasm of the infected cell forming paracrystalline arrays of close-packed isometric particles with a morphology similar to that described for authentic IBDV particles. The VLP have a buoyant density of 1n29 g\ml, which is similar to that of empty IBDV capsids produced after serial passage of the virus at high multiplicity (Mu$ ller et al., 1986) . EM observation of negatively stained purified VLP demonstrated that both their size and shape are identical to those of complete IBDV particles. Indeed, purified VLP were strongly recognized by anti-IBDV antisera.
Our results are in agreement with those described in a recently published report showing that expression of the IBDV polyprotein using a baculovirus vector leads to the formation of empty capsids which are recognized by conformationdependent anti-IBDV antibodies (Vakharia, 1997) .
It has been suggested that full immunological protection against IBDV requires the production of neutralizing antibodies against several VP2 conformational epitopes (Mu$ ller et al., 1992) . This might explain why both subunit vaccines based on purified VP2 and recombinant live vaccines, generated by insertion of the VP2 coding region within the genome of heterologous viruses, fail to match the protection levels induced after immunization with inactivated virus (Mu$ ller et al., 1992 ; Heine & Boyle, 1993 ; Vakharia et al., 1993 , Darteil et al., 1995 Pitcovski et al., 1996) . The structure of the VLP described in this report appears to be identical to that of complete IBDV particles. It seems likely that these VLP might induce an immune response similar to that elicited by inactivated virus. Experiments are under way to assess the potential of VLP for the generation of an effective vaccine against IBDV.
Despite their scientific interest and economic impact, many aspects of birnavirus biology remain poorly understood. The development of a reverse genetics approach to studying the virus has been a major breakthrough that is already yielding important results (Mundt & Vakharia, 1996 ; Mundt et al., 1997) . We hope that the expression system described in this report might also contribute to the development of strategies to gain a better understanding of IBDV and other members of the Birnaviridae.
